Salpingectomy at the Time of Elective Laparoscopic Cholecystectomy (SaLCHE)

NCT03171467 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-04-17

No results posted yet for this study

Summary

Prophylactic salpingectomy (also called opportunistic, risk-reducing or incidental salpingectomy) has been advocated at the time of gynecologic surgery to reduce the risk of serous ovarian cancer. This study explores the acceptability and feasibility of opportunistic salpingectomy at the time of elective laparoscopic cholecystectomy (LCHE).

Conditions

  • Prophylactic Salpingectomy
  • Opportunistic Salpingectomy
  • Laparoscopic Cholecystectomy

Interventions

PROCEDURE

Salpingectomy

Sponsors & Collaborators

  • Krankenhaus der Barmherzigen Brüder Graz

    collaborator UNKNOWN
  • Krankenhaus der Elisabethinen Graz

    collaborator UNKNOWN
  • Landeskrankenhaus Feldbach

    collaborator OTHER
  • LKH Hartberg

    collaborator UNKNOWN
  • Krankenhaus der Barmherzigen Brüder St. Veit/Glan

    collaborator UNKNOWN
  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Karl F Tamussino, MD · Medical University of Graz

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-08-01
Primary Completion
2018-04-01
Completion
2018-04-01

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03171467 on ClinicalTrials.gov